HPV阳性与阴性口咽癌中的C反应蛋白
前瞻性队列研究纳入113例HPV阳性与110例HPV阴性口咽癌患者,比较血浆CRP水平并分析其与总生存和无复发生存的关系。
要点
- HPV阳性口咽癌患者CRP水平显著高于HPV阴性患者。
- HPV阳性患者中CRP与生存无显著关联。
核心结论
- HPV阳性口咽癌的循环CRP高于HPV阴性口咽癌。
- HPV阴性患者中较高CRP与较差生存相关,但多因素分析无显著差异。
研究设计与样本
- 使用高灵敏度ELISA试剂盒测量血浆CRP水平。
- 采用多因素logistic回归比较4类CRP水平(低、中、高、极高)在HPV阳性与阴性组间的分布。
- 采用Kaplan-Meier法和Cox回归模型分析CRP与总生存及无复发生存的关系。
主要发现
- HPV阳性组CRP水平显著高于HPV阴性组,但未显示统计学显著的剂量反应趋势。
- HPV阳性组中,CRP水平与总生存或无复发生存均无显著关联(单因素和多因素分析)。
临床怎么用
- 在HPV阴性口咽癌患者中,CRP水平升高可能提示预后较差,可辅助风险分层。
- HPV阳性患者中CRP的预后价值有限,不宜单独用于生存预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Evaluate serum C-reactive protein (CRP) in human papillomavirus (HPV)-positive oropharynx cancer as compared with HPV-negative oropharynx cancer and determine if CRP levels were associated with overall survival and/or recurrence-free survival. STUDY DESIGN: Prospective cohort study. SETTING: Tertiary care academic cancer center between 2007 and 2010. SUBJECTS AND METHODS: Among patients with oropharynx cancer and confirmed HPV status, plasma CRP levels were measured with a high-sensitivity ELISA kit. Multivariable logistic regression analysis compared 4 categories of CRP (low, moderate, high, very high) between the HPV-positive and HPV-negative groups. Kaplan-Meier methods and Cox regression models were used to determine overall survival and recurrence-free survival by CRP level in both populations. RESULTS: Between 113 HPV-positive and 110 HPV-negative patients, CRP levels were significantly higher in the HPV-positive group, but these levels did not demonstrate a statistically significant dose-response trend. Higher CRP levels were also associated with reduced overall survival ( P = .016) and recurrence-free survival ( P < .001) within the HPV-negative group in univariable analysis; in multivariate analysis, the comparisons were not significantly different. Within HPV-positive oropharynx cancer, CRP levels were not significantly associated with overall survival or recurrence-free survival in univariable or multivariable analyses. CONCLUSION: Circulating CRP was higher in HPV-positive versus HPV-negative oropharynx cancer. Among HPV-negative patients, higher CRP levels were associated with reduced survival.
引用
- Johnson-Obaseki S, Caulley L, Corsten M, et al. C-reactive Protein in HPV-Positive and HPV-Negative Oropharyngeal Cancer. Otolaryngol Head Neck Surg. 2018. PMID: 30226795. doi:10.1177/0194599818800297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。